Technology-based group exercise interventions for people living with dementia or mild cognitive impairment: a scoping review protocol

Abstract

IntroductionMore than 50 million people worldwide are living with dementia in 2020, and this number is expected to double every 20 years. Physical exercise is a growing field in non-pharmacological interventions for dementia care. Due to public health measures during the COVID-19 pandemic, more people have considered adapting to technology-based exercise via digital devices. This scoping review will explore evidence relating to the use of technology-based group exercise by people with dementia or mild cognitive impairment.Methods and analysisThis review will follow the Joanna Briggs Institute scoping review methodology to review literature published between June and December 2021. This review is designed to identify existing types of technology-based group exercise interventions for people with dementia. The review will provide a synthesis of current evidence on the outcome and impacts of technology-based group exercise. The context of this review will include homes, assisted living facilities and memory care services but exclude hospitals. The review will include a three-step search strategy: (a) identify keywords from MEDLINE and Embase, (b) search using the identified keywords in databases (MEDLINE/PubMed, CINAHL, Web of Science, Embase, Cochrane Library, PsychInfo and Google) and (c) review references from included studies to identify additional studies. Only studies in English will be included. Four researchers will independently assess titles and abstracts and then review the full text of the selected articles, applying the inclusion criteria. The extracted data will be presented in tables and summarised narratively.Ethics and disseminationScoping review data will be collected from publicly available articles; research ethics approval is not required. The findings will be disseminated to healthcare practitioners and the public through a peer-reviewed publication and conference presentations.

How Alpha Linolenic Acid May Sustain Blood–Brain Barrier Integrity and Boost Brain Resilience against Alzheimer’s Disease

“…Worldwide, the number of people with dementia is about 55 million and this number is expected to double every 20 years [ 7 ], making dementia a major epidemic of this century. However, currently approved drugs primarily treat symptoms and have limited impact on the course of disease.…”

A Literature Review of High-Tech Physiotherapy Interventions in the Elderly with Neurological Disorders

“…Generally, a successful application of telemedicine technologies and smart environments should meet criteria of robustness, safety, and usability for patients; to be scalable and fitting regarding social, technical, and economic aspects and infrastructures; and finally, to be able to motivate and be transparent for patients, caregivers, health professionals, and regulatory organizations in order to increase confidence in rehabilitation technology for a home model so that all stakeholders will embrace them [ 165 , 171 ]. Such a shift from a traditional to modern telemedicine-assisted physiotherapy methods is expected to occur and the pandemic can act as an accelerator for the adoption by patients, caregivers, and rehabilitation professionals and for market penetration of the proposed technological rehabilitation [ 172 , 173 , 174 , 175 ].…”

Alzheimer’s Disease and SARS-CoV-2: Pathophysiological Analysis and Social Context

“…On the contrary, if the patient is not used to indulging in physical activity, it is recommended that they start with a light exercise adapted in intensity and duration, taking into account their physical and general conditions. It is important to avoid exercise that may cause discomfort or pain, and to stop the session if the patient is uncomfortable [ 69 ].…”